ZYLIDAC
LIVE

Serial Number

99410754

Owner

Zylidac Bio LLC

Attorney

Anthony J. DiMarino

Filing Date

Sep 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ZYLIDAC Trademark

Serial Number: 99410754

ZYLIDAC is a trademark filed by Zylidac Bio LLC on September 24, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Zylidac Bio LLC (5 trademarks)

73 Route 31 N
Pennington, NJ 08534

Entity Type: 03

Trademark Details

Filing Date

September 24, 2025

Registration Date

Not Registered

Published for Opposition

April 14, 2026

Goods & Services

Medical services; Medical clinics; Health care services, namely, wellness programs; Providing a website featuring information about health, wellness and nutrition; Providing information in the fields of health and wellness; Managed health care services; Consulting services in the field of healthcare

Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals; Reagents for scientific or medical research use; Reagents for research purposes; Reagents for scientific purposes; Reagents for scientific use; Chemical diagnostic reagents for scientific use

Research and development in the field of pharmaceuticals; Development of products for others in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Development of pharmaceuticals for cell and gene therapies; Research and development of new products; Technical consulting in the field of pharmaceutical studies; Research and development services of new pharmaceutical products; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Biomedical research services

Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process; Custom manufacture of cancer vaccines; Custom manufacturing of pharmaceuticals

Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Health food supplements; Nutraceuticals for use as a dietary supplement; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical reagents for medical use; Chemical reagents for medical or veterinary use; Diagnostic chemical reagents for medical purposes; Diagnostic chemical reagents for medical use; Reagents for medical use; Clinical medical reagents; Dietary and nutritional supplements; Dietary food supplements; Vitamin and mineral supplements; Herbal supplements; Human vaccine preparations; Vaccine preparations

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 9, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 17, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 17, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 17, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 17, 2026 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 17, 2026 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 10, 2026 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2026 CNSA
ASSIGNED TO EXAMINER
Feb 17, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 24, 2025 MAFR
NEW APPLICATION ENTERED
Sep 24, 2025 NWAP